CoronaVIR Frequently Asked Questions
CoronaVIR is an integrative multi-omics platform dedicated to the Corona virus genomic and proteomic analysis along with comparative genomics and therapeutic knowledge.
It is classified in different sections represent individual components i.e. genomic annotation, therapeutics, molecular diagnostics, comparative genomic analysis and tools.
Upto now, there is no resoruce available for Corona virus study, We have analyzed and compiled complete genomic, proteomic and structural data along with therapeutically potential candidates. It is the first of its kind and very important since it addresses overall landscape of Corona virus. It also facilitate useful analysis tools.
This integrated resource is freely available to facilitate research on Coronavirus, All curated and annotated genomic data can also be downloaded to perform in-house analysis.
It can be publically accessed from our website
https://webs.iiitd.edu.in/raghava/coronavir/
A novel coronavirus (nCoV) is a new coronavirus that has not been previously identified. The 2019 novel coronavirus (2019-nCoV), is not that same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.
A diagnosis with coronavirus 229E, NL63, OC43, or HKU1 is not the same as a 2019-nCoV diagnosis. These are different viruses and patients with 2019-nCoV will be evaluated and cared for differently than patients with common coronavirus diagnosis.
Public health officials and partners are working hard to identify the source of the 2019-nCoV. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats. Analysis of the genetic tree of this virus is ongoing to know the specific source of the virus. SARS, another coronavirus that emerged to infect people, came from civet cats, while MERS, another coronavirus that emerged to infect people, came from camels. More information about the source and spread of 2019-nCoV is available on the 2019-nCoV Situation Summary: Source and Spread of the Virus.
This virus probably originally emerged from an animal source but now seems to be spreading from person-to-person. It’s important to note that person-to-person spread can happen on a continuum. Some viruses are highly contagious (like measles), while other viruses are less so. At this time, it’s unclear how easily or sustainably this virus is spreading between people. Learn what is known about the spread of newly emerged coronaviruses.
There is still a lot that is unknown about the newly emerged 2019 novel coronavirus (2019-nCoV) and how it spreads. Two other coronaviruses have emerged previously to cause severe illness in people (MERS and SARS). 2019-nCoV is more genetically related to SARS than MERS, but both are betacoronaviruses with their origins in bats. While we don’t know for sure that this virus will behave the same way as SARS and MERS, we can use the information from both of these earlier coronaviruses to guide us. In general, because of poor survivability of these coronaviruses on surfaces, there is likely very low risk of spread from products or packaging that are shipped over a period of days or weeks at ambient temperatures. Coronaviruses are generally thought to be spread most often by respiratory droplets. Currently there is no evidence to support transmission of 2019-nCoV associated with imported goods and there have not been any cases of 2019-nCoV in the United States associated with imported goods. Information will be provided on the 2019 Novel Coronavirus website as it becomes available.